SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-213583
Filing Date
2022-08-05
Accepted
2022-08-05 16:06:07
Documents
5
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d341851ddef14a.htm DEF 14A 579701
2 GRAPHIC g341851g46n24.jpg GRAPHIC 14375
3 GRAPHIC g341851g50v17.jpg GRAPHIC 39024
4 GRAPHIC g341851g75s04.jpg GRAPHIC 149655
5 GRAPHIC g341851g76s05.jpg GRAPHIC 122951
  Complete submission text file 0001193125-22-213583.txt   1014670
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38266 | Film No.: 221140774
SIC: 2834 Pharmaceutical Preparations